Alkane Resources Valuation
Is AK7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AK7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AK7 (€0.29) is trading below our estimate of fair value (€6.9)
Significantly Below Fair Value: AK7 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AK7?
Key metric: As AK7 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is AK7's PE Ratio? | |
|---|---|
| PE Ratio | 17.3x |
| Earnings | AU$17.68m |
| Market Cap | AU$305.56m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.8x |
| Enterprise Value/EBITDA | 5.2x |
| PEG Ratio | 0.5x |
Price to Earnings Ratio vs Peers
How does AK7's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 15.2x | ||
EIS Eisen- und Hüttenwerke | 18.5x | n/a | €202.4m |
UZU Uzin Utz | 10.5x | 2.1% | €250.2m |
2HRA H&R GmbH KGaA | 23.2x | 52.9% | €128.4m |
NTG Nabaltec | 8.7x | 4.3% | €122.3m |
AK7 Alkane Resources | 17.3x | 36.3% | €305.6m |
Price-To-Earnings vs Peers: AK7 is expensive based on its Price-To-Earnings Ratio (17.3x) compared to the peer average (15.2x).
Price to Earnings Ratio vs Industry
How does AK7's PE Ratio compare vs other companies in the European Metals and Mining Industry?
| 14 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 14 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: AK7 is expensive based on its Price-To-Earnings Ratio (17.3x) compared to the European Metals and Mining industry average (12.1x).
Price to Earnings Ratio vs Fair Ratio
What is AK7's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 17.3x |
| Fair PE Ratio | 23x |
Price-To-Earnings vs Fair Ratio: AK7 is good value based on its Price-To-Earnings Ratio (17.3x) compared to the estimated Fair Price-To-Earnings Ratio (23x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €0.29 | €0.52 +77.5% | 34.6% | €0.77 | €0.34 | n/a | 3 |
| Nov ’25 | €0.31 | €0.52 +68.3% | 34.6% | €0.77 | €0.34 | n/a | 3 |
| Oct ’25 | €0.24 | €0.48 +98.7% | 32.5% | €0.68 | €0.31 | n/a | 3 |
| Sep ’25 | €0.24 | €0.46 +92.8% | 34.0% | €0.67 | €0.30 | n/a | 3 |
| Aug ’25 | €0.24 | €0.48 +97.4% | 31.2% | €0.69 | €0.34 | n/a | 3 |
| Jul ’25 | €0.28 | €0.47 +69.2% | 33.1% | €0.69 | €0.34 | n/a | 3 |
| Jun ’25 | €0.32 | €0.58 +80.7% | 25.8% | €0.77 | €0.40 | n/a | 3 |
| May ’25 | €0.37 | €0.58 +59.0% | 25.8% | €0.77 | €0.40 | n/a | 3 |
| Apr ’25 | €0.36 | €0.51 +43.2% | 12.7% | €0.60 | €0.45 | n/a | 3 |
| Mar ’25 | €0.28 | €0.51 +83.1% | 12.7% | €0.60 | €0.45 | n/a | 3 |
| Feb ’25 | €0.33 | €0.55 +65.2% | 12.0% | €0.61 | €0.45 | n/a | 3 |
| Jan ’25 | €0.38 | €0.56 +46.0% | 14.1% | €0.63 | €0.45 | n/a | 3 |
| Dec ’24 | €0.38 | €0.56 +48.3% | 14.1% | €0.63 | €0.45 | n/a | 3 |
| Nov ’24 | €0.33 | €0.52 +58.7% | 14.3% | €0.60 | €0.45 | €0.31 | 2 |
| Oct ’24 | €0.34 | €0.61 +77.9% | 2.4% | €0.62 | €0.59 | €0.24 | 2 |
| Sep ’24 | €0.37 | €0.61 +66.3% | 2.4% | €0.62 | €0.59 | €0.24 | 2 |
| Aug ’24 | €0.41 | €0.63 +54.3% | 2.4% | €0.64 | €0.61 | €0.24 | 2 |
| Jul ’24 | €0.41 | €0.65 +58.9% | 4.8% | €0.68 | €0.61 | €0.28 | 2 |
| Jun ’24 | €0.43 | €0.65 +51.5% | 4.8% | €0.68 | €0.61 | €0.32 | 2 |
| May ’24 | €0.52 | €0.65 +25.3% | 4.8% | €0.68 | €0.61 | €0.37 | 2 |
| Mar ’24 | €0.42 | €0.70 +65.9% | 9.1% | €0.76 | €0.64 | €0.28 | 2 |
| Feb ’24 | €0.42 | €0.69 +64.6% | 4.8% | €0.72 | €0.65 | €0.33 | 2 |
| Jan ’24 | €0.36 | €0.67 +86.6% | 4.8% | €0.70 | €0.64 | €0.38 | 2 |
| Dec ’23 | €0.40 | €0.67 +66.7% | 4.8% | €0.70 | €0.64 | €0.38 | 2 |
| Nov ’23 | €0.39 | €0.67 +72.3% | 4.8% | €0.70 | €0.64 | €0.33 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Stanmore Resources
AU$2.8b
Engages in the exploration, development, production, and sale of metallurgical coal in Australia.
S0D
AU$1.88
7D
0.5%
1Y
-16.8%
Tokuyama
JP¥197.6b
Produces and sells various chemical products in Japan.
TBT
JP¥16.70
7D
5.0%
1Y
16.0%
Mitsubishi Chemical Group
JP¥1.2t
Provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally.
M3C
JP¥5.27
7D
2.9%
1Y
-8.1%